Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
A/Prof Thomas Shakespeare
Trust score 8/100 Accepting new patients

A/Prof

A/Prof Thomas Shakespeare

Oncology

English
8,204+ Patients seen
10 Years in practice
8 Publications
1 Languages spoken

About

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— A/Prof Thomas Shakespeare

Education & training

  1. 2006–2012 MD · Medicine and Surgery
    Universitat de Barcelona
  2. 2012–2016 Residency · Oncology
    UAB Barcelona
  3. 2016–2017 Fellowship · Subspecialty training
    AP-HP Paris, FR

Career & appointments

  1. 2016-09–2017-08 Junior consultant
    Universitat de Barcelona Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

— Organización Médica Colegial de España (OMC)
#-672631 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-3BDDE523 · issued 2017 · renewal 2027
Malpractice insurance: AXA Healthcare Liability · 1,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 2,507
Annual physical exam 99395 957
Vaccination administration 90471 565
Minor procedure (skin) 17110 2,186

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 120 min in_clinic 540.00 EUR
Minor procedure (skin) 30 min in_clinic 810.00 EUR

Office, team & in practice

Thomas Shakespeare in consultation
IN OFFICE
Thomas Shakespeare with the team
WITH TEAM
Thomas Shakespeare at a conference
CONFERENCE

Videos

introduction · 123s
Meet Thomas Shakespeare

Research & publications

h-index: 15 · i10: 14

  1. European registry analysis of Oncology outcomes
    Thomas Shakespeare, et al. · European Journal of Medicine, 2025
    DOI: 10.9399/euroclin.2025.0 · PMID: 34356707 · cited by 3
  2. Outcomes of Oncology in adults — a multi-centre cohort
    Thomas Shakespeare, et al. · European Journal of Medicine, 2024
    DOI: 10.6656/euroclin.2024.1 · PMID: 35143245 · cited by 49
  3. European registry analysis of Oncology outcomes
    Thomas Shakespeare, et al. · European Journal of Medicine, 2023
    DOI: 10.6928/euroclin.2023.2 · PMID: 34707426 · cited by 135
  4. Outcomes of Oncology in adults — a multi-centre cohort
    Thomas Shakespeare, et al. · European Journal of Medicine, 2022
    DOI: 10.7274/euroclin.2022.3 · PMID: 37114822 · cited by 5

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2017
  • national college of family doctors — Member · since 2017
  • European Union of Medical Specialists (UEMS) — Member · since 2017

Patient reviews

★ 0.00 0 verified reviews
Bedside Manner
0.05
Knowledge
0.08
Wait Time
3.80
Staff Friendliness
0.02
Ease Of Appointment
4.00
Value For Money
4.10
Would Recommend Pct
4
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-26

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-11

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-04

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · thomas.shakespeare@euroclinics.example

Similar specialists

Browse all →